<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="iso-abbrev">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="pmc-domain-id">82</journal-id><journal-id journal-id-type="pmc-domain">aac</journal-id><journal-id journal-id-type="publisher-id">aac</journal-id><journal-title-group><journal-title>Antimicrobial Agents and Chemotherapy</journal-title></journal-title-group><issn pub-type="ppub">0066-4804</issn><issn pub-type="epub">1098-6596</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11881564</article-id><article-id pub-id-type="pmcid-ver">PMC11881564.1</article-id><article-id pub-id-type="pmcaid">11881564</article-id><article-id pub-id-type="pmcaiid">11881564</article-id><article-id pub-id-type="pmid">39927767</article-id><article-id pub-id-type="doi">10.1128/aac.00053-24</article-id><article-id pub-id-type="publisher-id">aac00053-24</article-id><article-id pub-id-type="publisher-id">aac.00053-24</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Mechanisms of Resistance</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">parasitology</compound-subject-part><compound-subject-part content-type="label">Parasitology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Isolation and characterization of <italic toggle="yes">Plasmodium falciparum</italic> blood-stage persisters by improved selection protocols using dihydroartemisinin alone</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0797-7378</contrib-id><name name-style="western"><surname>Kiboi</surname><given-names initials="D">Daniel</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>S&#225;</surname><given-names initials="JM">Juliana M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nayak</surname><given-names initials="A">Akshaykumar</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Micchelli</surname><given-names initials="CE">Chiara E.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Amin</surname><given-names initials="SN">Shuchi N.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Burbelo</surname><given-names initials="AG">Alexander G.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Abielmona</surname><given-names initials="SA">Sasha A.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xi</surname><given-names initials="B">Brian</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mulei</surname><given-names initials="LA">Lucia A.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2462-139X</contrib-id><name name-style="western"><surname>Onchieku</surname><given-names initials="NM">Noah M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Percopo</surname><given-names initials="CM">Caroline M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6012-8389</contrib-id><name name-style="western"><surname>Mu</surname><given-names initials="J">Jianbing</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3899-8454</contrib-id><name name-style="western"><surname>Wellems</surname><given-names initials="TE">Thomas E.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review and editing</role><email>twellems@niaid.nih.gov</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases</institution><institution-id institution-id-type="Ringgold">550430</institution-id></institution-wrap>, <city>Bethesda</city>, <state>Maryland</state>, <country>USA</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology</institution><institution-id institution-id-type="Ringgold">118985</institution-id></institution-wrap>, <city>Nairobi</city>, <country>Kenya</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name name-style="western"><surname>Odom John</surname><given-names initials="A">Audrey</given-names></name><aff><institution-wrap><institution>The Children's Hospital of Philadelphia</institution></institution-wrap>, <city>Philadelphia</city>, <state>Pennsylvania</state>, <country>USA</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Thomas E. Wellems, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:twellems@niaid.nih.gov">twellems@niaid.nih.gov</email></corresp><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>3</month><year>2025</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>2</month><year>2025</year></pub-date><volume>69</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">483535</issue-id><elocation-id>e00053-24</elocation-id><history><date date-type="received"><day>12</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>12</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>06</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-02 01:25:34.400"><day>02</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.</copyright-statement><ali:free_to_read start_date="2025-02-10"/><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="aac.00053-24.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="aac.00053-24.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p>Artemisinin-based combination therapies (ACTs) are vital for malaria treatment, but these are threatened by blood-stage persisters&#8212;dormant forms of <italic toggle="yes">Plasmodium</italic> parasites that can survive drug exposure and cause recrudescent infections. Here, we present improved protocols for efficient preparation of pure <italic toggle="yes">Plasmodium falciparum</italic> persister populations without the need for magnetically activated columns, sorbitol exposure, or prolonged manipulations. Our protocols transformed actively replicating parasites into persister populations by exposing mixed blood-stage parasites to three or four consecutive daily 6 h pulses of 700 nM or 200 nM dihydroartemisinin (DHA). In micrographs of Giemsa-stained cells, we observed different persister morphologies: Type I persisters containing a rounded magenta-stained nucleus accompanied by a local region of blue-stained cytoplasm; and the more-prevalent Type II persisters characterized by a dark round or irregular-appearing nucleus and faded or no detectable cytoplasm. We also observed cells with disorganized nuclear and cytoplasmic structure, suggesting possible autophagic processes of destruction and remodeling. Recrudescence of actively replicating parasites to starting parasitemia or higher occurred around 17&#8211;22 days after initial DHA exposure. Differential expression patterns of the acetyl CoA carboxylase (<italic toggle="yes">acc</italic>) and skeleton binding protein 1 (<italic toggle="yes">sbp1</italic>) genes during DHA treatment, dormancy, and recrudescence highlighted the evolution of physiologic states and metabolic changes underlying persister formation and recovery. Our findings suggest hypotheses and questions for further research to understand the cellular pathways of dormancy and uncover strategies to thwart parasite survival after drug exposure.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>malaria</kwd><kwd>artemisinin</kwd><kwd>autophagy</kwd><kwd>dormancy</kwd><kwd>drug resistance</kwd><kwd>recrudescence</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award-1"><funding-source><institution-wrap><institution>HHS | NIH | NIAID | Division of Intramural Research (DIR, NIAID)</institution></institution-wrap></funding-source><award-id>AI000483</award-id><principal-award-recipient><name name-style="western"><surname>Nayak</surname><given-names>Akshaykumar</given-names></name><name name-style="western"><surname>Kiboi</surname><given-names>Daniel</given-names></name><name name-style="western"><surname>S&#225;</surname><given-names>Juliana M.</given-names></name><name name-style="western"><surname>Micchelli</surname><given-names>Chiara E.</given-names></name><name name-style="western"><surname>Amin</surname><given-names>Shuchi N.</given-names></name><name name-style="western"><surname>Burbelo</surname><given-names>Alexander G.</given-names></name><name name-style="western"><surname>Abielmona</surname><given-names>Sasha A.</given-names></name><name name-style="western"><surname>Xi</surname><given-names>Brian</given-names></name><name name-style="western"><surname>Mulei</surname><given-names>Lucia A.</given-names></name><name name-style="western"><surname>Onchieku</surname><given-names>Noah M.</given-names></name><name name-style="western"><surname>Percopo</surname><given-names>Caroline M.</given-names></name><name name-style="western"><surname>Mu</surname><given-names>Jianbing</given-names></name><name name-style="western"><surname>Wellems</surname><given-names>Thomas E.</given-names></name></principal-award-recipient></award-group></funding-group><counts><count count="2" count-type="supplementary-material"/><count count-type="authors" count="13"/><fig-count count="4"/><ref-count count="72"/><page-count count="17"/><word-count count="10566"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Artemisinin and its semisynthetic derivatives (ART) are essential drugs used worldwide against <italic toggle="yes">Plasmodium falciparum</italic> infections (<xref rid="B1" ref-type="bibr">1</xref>), but despite their ability to rapidly clear the parasitemia and symptoms of malaria, recrudescences have been frequently observed after courses of ART monotherapy, even when administered daily for 3 days or longer (<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">&#8211;</xref><xref rid="B5" ref-type="bibr">5</xref>). These recrudescences are thought to arise from subpopulations of parasites (persisters) that enter a state of dormancy, circulating in the bloodstream for days or weeks before reactivating to initiate new infections (<xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">&#8211;</xref><xref rid="B12" ref-type="bibr">12</xref>). The inherent ability of malaria parasites to survive drug exposure through dormancy is supported by observations of recrudescences in primate and rodent <italic toggle="yes">Plasmodium</italic> infections after ART treatment, as well as the lack of association between changes in ART half-maximum inhibitory concentrations (IC<sub>50</sub>s) and observed parasite clearance times or treatment outcomes <italic toggle="yes">in vivo</italic> (<xref rid="B13" ref-type="bibr">13</xref><xref rid="B14" ref-type="bibr">&#8211;</xref><xref rid="B17" ref-type="bibr">17</xref>). Like in cancer and bacteria research, various terms, such as dormant, quiescent, tolerant or persister cells, have been used to describe these growth-arrested, non-replicating subpopulations that survive drug exposure (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B18" ref-type="bibr">18</xref><xref rid="B19" ref-type="bibr">&#8211;</xref><xref rid="B20" ref-type="bibr">20</xref>). In this study, we refer to these malaria parasites as dormant forms or persisters.</p><p>While dormancy has been widely studied in <italic toggle="yes">Plasmodium</italic> parasites exposed to ART, it is not unique to this class of drugs. The concept of <italic toggle="yes">P. falciparum</italic> survival through dormancy was first proposed based on <italic toggle="yes">in vitro</italic> experiments with parasites exposed to sorbitol or pyrimethamine for four consecutive days (<xref rid="B21" ref-type="bibr">21</xref>). Subsequent laboratory studies demonstrated dormancy in <italic toggle="yes">P. falciparum</italic> cultures after exposure to ART (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B22" ref-type="bibr">22</xref>) and other drugs, including mefloquine (<xref rid="B23" ref-type="bibr">23</xref>), atovaquone (<xref rid="B24" ref-type="bibr">24</xref>), and chloroquine (<xref rid="B25" ref-type="bibr">25</xref>). ART-induced dormancy has received particular attention due to the drug&#8217;s critical role in malaria treatment and the challenges that persisters pose for artemisinin-based combination therapy (ACT), as they demand effective partner drugs for complete clearance of infections. The clinical significance of dormancy has been underscored by analyses of treatment outcomes and results from animal malaria models, highlighting the importance of effective partner drugs in preventing recrudescences (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B26" ref-type="bibr">26</xref>).</p><p>Recent molecular studies have provided insights into mechanisms underlying parasite dormancy. Cell cycle regulation may play a crucial role in this process, as studies of cyclin-dependent kinases, including cdc2-related protein kinase 1 (<italic toggle="yes">crk1</italic>) and cdc2-related protein kinase 4 (<italic toggle="yes">crk4</italic>), have shown correlations with cell cycle stalling at the G- to S-phase transition during dormancy (<xref rid="B27" ref-type="bibr">27</xref>). Metabolic pathways also seem to be involved, including those found in the apicoplast and mitochondrion. Transcriptomic analyses have revealed upregulation of genes encoding key enzymes in fatty acid synthesis and pyruvate metabolism, including pyruvate kinase 2 (<italic toggle="yes">pykii</italic>), a putative elongation of fatty acid homologue (<italic toggle="yes">elo3</italic>), acetyl&#8211;CoA carboxylase (<italic toggle="yes">acc</italic>), lipoyl synthase (<italic toggle="yes">lipA</italic>), and biotin&#8211;protein ligase 1 (<italic toggle="yes">hcs1</italic>) (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B28" ref-type="bibr">28</xref>). The importance of <italic toggle="yes">acc</italic> upregulation was further confirmed in a controlled human malaria infection study, in which dormant parasites showed increased expression of this gene 72 hours after treatment with a single oral dose of artesunate (<xref rid="B11" ref-type="bibr">11</xref>). Downregulation of most cellular functions associated with growth and development but upregulation of certain other functions and DNA repair, consistent with both cellular quiescence and senescence, were recently reported from transcriptional profiling study of DHA-induced persisters (<xref rid="B29" ref-type="bibr">29</xref>). Additionally, skeleton-binding protein 1 (<italic toggle="yes">sbp1</italic>), a component of the Maurer&#8217;s cleft (<xref rid="B30" ref-type="bibr">30</xref><xref rid="B31" ref-type="bibr">&#8211;</xref><xref rid="B32" ref-type="bibr">32</xref>), has been associated with parasite persistence in patients treated with ART, as well as non-ART drugs (<xref rid="B33" ref-type="bibr">33</xref><xref rid="B34" ref-type="bibr">&#8211;</xref><xref rid="B35" ref-type="bibr">35</xref>). Notably, <italic toggle="yes">sbp1</italic> transcripts are primarily found in the asexual ring stage (<xref rid="B36" ref-type="bibr">36</xref><xref rid="B37" ref-type="bibr">&#8211;</xref><xref rid="B38" ref-type="bibr">38</xref>), further supporting the hypothesis that this early stage may be particularly prone to entering dormancy.</p><p>Various laboratory protocols have been employed to study the dormancy and recrudescence of <italic toggle="yes">P. falciparum in vitro</italic> (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>). A common approach employs a single 6 h exposure of synchronized, early ring-stage parasites to 700 nM dihydroartemisinin (DHA). However, two issues can arise with this method as usually implemented. First, to obtain highly synchronous parasites (<italic toggle="yes">ca</italic>. 95%), two rounds of sorbitol treatments are typically performed 2 days before the start of DHA exposure to ensure that predominantly &lt;6 h-old ring stages receive the DHA pulse (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). A previous study showed sorbitol itself can select dormant parasites (<xref rid="B21" ref-type="bibr">21</xref>), which may confound the interpretation of experiments designed to study dormancy after exposure to DHA or other compounds. The second issue is the need to be sure no active-stage parasites remain that may not have become dormant or killed by the single 6 h DHA pulse. Mature active stages can be removed by passing the culture through magnetic-activated cell sorting columns (MACS, Miltenyi Biotec) or by sorbitol treatments for three consecutive days after the DHA exposure (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B39" ref-type="bibr">39</xref>). However, as the MACS columns are expensive, and both MACS and sorbitol treatment protocols are time-consuming and cumbersome, improved methods are desirable for the efficient preparation and study of dormant parasites.</p><p>Multiple daily DHA pulses on unsynchronized parasite cultures offer an alternative to the above protocols. In a previous study, Teuscher et al. (<xref rid="B7" ref-type="bibr">7</xref>) examined the recovery rates of dormant parasites after three daily 6 h 700 nM DHA treatments without MACS column purifications. However, sorbitol synchronization was still applied 2 days before the first DHA treatment. In drug susceptibility experiments on dormant parasites, Reyser et al. (<xref rid="B42" ref-type="bibr">42</xref>) initiated quiescence using a single 6 h 700 nM DHA pulse and then continued exposure of the parasites to 700 nM DHA plus various test compounds for an additional 48 h. Building on these approaches, we present efficient and easily performed protocols for the routine production of dormant <italic toggle="yes">P. falciparum</italic> parasites without the need for sorbitol treatments or MACS column purifications. Using these protocols with three or four consecutive daily 6 h exposures of 200&#8211;700 nM DHA, we show how persister populations can be purified by fluorescence-activated cell sorting (FACS), characterized by cellular studies, and analyzed for molecular processes potentially involved in dormancy and recrudescence. Our results suggest hypotheses and questions for further research to understand the persister state, illuminate the cellular and signaling events of dormancy, and uncover strategies to thwart parasite survival after drug exposure.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2-1"><title>Recrudescences from unsynchronized parasites after treatment with multiple daily pulses of DHA</title><p>To develop a protocol for routine and inexpensive production of <italic toggle="yes">P. falciparum</italic> persisters without the need for synchronization, column purifications, or sorbitol treatment after DHA exposure, we subjected asynchronous <italic toggle="yes">P. falciparum</italic> cultures of GB4 and 803 parasites (1.5&#8211;2% initial parasitemia) to daily 6 h pulses of 700 or 200 nM DHA for four consecutive days (4DP protocol). This 4DP treatment period spanned the equivalent of two complete asexual cycles of untreated parasites (<xref rid="SuF1" ref-type="supplementary-material">Fig. S1</xref>). The 700 nM DHA concentration (200 ng/mL) was based on its use to induce dormancy in previous studies (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B39" ref-type="bibr">39</xref>). The 200 nM concentration (57 ng/mL) was chosen to represent a level in the 6 h range of the smaller peaks of plasma DHA reported after four-tablet doses of artemether (80 mg total) + lumefantrine (480 mg total) in Thai patients (<xref rid="B43" ref-type="bibr">43</xref>). After each pulse, the cells were pelleted by centrifugation, washed twice in culture medium, and immediately returned to culture. No sorbitol exposure was applied to the parasites prior to or during the experiments.</p><p>Following the first daily pulse of DHA, we observed rapid reductions of actively replicating ring, trophozoite, and schizont (RTS) stages (<xref rid="F1" ref-type="fig">Fig. 1A and B</xref>) in agreement with previous results from <italic toggle="yes">P. falciparum</italic> lines GB4 and 803 and other parasite clones (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B44" ref-type="bibr">44</xref>). In concert with this decline, persisters quickly rose in the counts and remained present in culture for the duration of the experiment. Using Giemsa dye for microscopy visualization, we classified these persisters according to the morphologies described by Tucker et al. (<xref rid="B45" ref-type="bibr">45</xref>): dormant-like persisters (hereafter referred to as Type I) were identified by a small, rounded magenta-stained nucleus and accompanying blue-stained cytoplasm; and pyknotic-like persisters (Type II) contained a dark round or irregular-appearing nucleus accompanied by faded or no detectable cytoplasm. Type II persisters consistently outnumbered the Type I persisters in our data. Whether treated with 700 or 200 nM DHA, the GB4 and 803 parasites in these 4DP assays recrudesced to starting parasitemia levels or higher 17&#8211;22 days after the first dose of DHA (<xref rid="F1" ref-type="fig">Fig. 1A and B</xref>). Among the persisters, we also observed variable numbers of parasites with degenerative changes resembling crisis forms (<xref rid="B46" ref-type="bibr">46</xref><xref rid="B47" ref-type="bibr">&#8211;</xref><xref rid="B48" ref-type="bibr">48</xref>).</p><fig position="float" fig-type="figure" id="F1" orientation="portrait"><label>Fig 1</label><caption><p>Recrudescence assay results from asynchronous cultures of <italic toggle="yes">P. falciparum</italic> parasites exposed to daily 6 h pulses of dihydroartemisinin (DHA). Pulses of 700 or 200 nM DHA were given on the days indicated by the arrows. (<bold>A</bold>) Results from <italic toggle="yes">P. falciparum</italic> line GB4, which contains no mutations in the PfK13 propeller region, exposed to four 6 h daily pulses of 700 or 200 nM DHA (4DP protocol). (<bold>B</bold>) 4DP results from <italic toggle="yes">P. falciparum</italic> line 803, which contains the C580Y mutation in the PfK13 propeller region. (<bold>C</bold>) Results from <italic toggle="yes">P. falciparum</italic> line GB4 exposed to three 6 h daily pulses of 700 or 200 nM DHA (3DP protocol). (<bold>D</bold>) 3DP results from <italic toggle="yes">P. falciparum</italic> line 803. Parasitemia percentages of actively growing blood stage forms (RTS; rings, trophozoites, and schizonts) are indicated by solid blue lines. Parasitemia percentages of Type I and II persisters are represented by the dashed red and gray lines, respectively, and those of crisis-like forms by the dashed black lines. No gametocytes were observed in these experiments. Counts for analysis were recorded from each Giemsa-stained thin blood film by at least two microscopists blinded to slide identification. Points and error bars represent the means and standard deviations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="aac.00053-24.f001.jpg"><alt-text>Line graphs display parasitemia percentages over 22 days for different parasite forms (R + T + S, Type I, Type II, crisis-like forms) treated with three or four daily pulses of 700 nM or 200 nM DHA.</alt-text></graphic></fig><p>Having characterized the recrudescences and persisters from 4DP assays with 700 nM DHA, we investigated whether similar results could be obtained from three daily 6 h drug pulses (3DP protocol) applied to asynchronous parasitized red blood cells (pRBC) from <italic toggle="yes">P. falciparum</italic> cultures. This program of 3DP exposure aligns with the 3-day period typical of artemisinin-based combination therapy (ACT) used for malaria treatment. After we exposed GB4 and 803 parasites to the three daily 6 h pulses of 700 or 200 nM DHA, we found rapid reductions of actively replicating RTS accompanied by the appearance of Type I and II persisters as in the 4DP assays (<xref rid="F1" ref-type="fig">Fig. 1C and D</xref>). Recrudescences above the level of the starting parasitemia percentage was observed around day 18. These results suggest that 3DP was as effective as the 4DP protocol for clinically relevant studies of ART-induced dormancy and ACT partner drug resistance.</p></sec><sec id="s2-2"><title>Flow cytometry, purification, and characterization of ART-treated parasites from recrudescence assays</title><p>The persisters in these experiments were detected by flow cytometry of cells doubly stained with SYBR Green I (SG, nucleic acid dye) and MitoTracker Deep Red (MT, mitochondrial membrane potential dye). In MACSQuant Analyzer displays of GB4 and 803 parasites exposed to 4DP (700 nM), persisters presented as a clustered population above and slightly to the right of the center of uninfected erythrocytes (uRBC) due to their SG and MT fluorescence (<xref rid="SuF1" ref-type="supplementary-material">Fig. S3A and B</xref>). Between days 2 and 15, the parasitemia percentages in these clusters ranged from 1.31 to 2.55% for GB4 and 2.06 to 2.91% for 803 parasites. Compared to the clusters of persisters during dormancy, the distributions of recrudescing RTS populations showed rightward and upward extensions of more brightly fluorescing SG<sup>+</sup>/MT<sup>+</sup> cells. This pattern is consistent with the greater DNA content and mitochondrial activity of the trophozoite and schizont stages (<xref rid="SuF1" ref-type="supplementary-material">Fig. S3A</xref>, days 17 and 20, and asynchronous control panel; <xref rid="SuF1" ref-type="supplementary-material">Fig. S3B</xref>, days 14&#8211;18 and asynchronous control panel).</p><p>To further study the changes accompanying <italic toggle="yes">P. falciparum</italic> persistence and recrudescence, we used FACS to isolate and analyze purified populations of pRBC (803 line) at days 2, 4, 9, 11, 14, 16, 18, and 23 of 4DP with 700 nM DHA. A BD Aria Fusion flow cytometer was employed in a two-step process using yield mode for initial enrichment, followed by four-way purity mode for precise separation of parasite populations. This approach allowed us to isolate and collect cells from samples stained with SG and MT. In the first yield-sorting step, samples were assessed for SG fluorescence, and all SG<sup>+</sup> cells (including persisters and any RTS stages) were collected by high-throughput gating (<xref rid="F2" ref-type="fig">Fig. 2A through H</xref>, left panels). The parasitemia percentages in this SG<sup>+</sup> gate were consistent with the frequencies of persisters plus RTS stages estimated from Giemsa-stained thin films (<xref rid="F1" ref-type="fig">Fig. 1B</xref>) or MACSQuant data (<xref rid="SuF1" ref-type="supplementary-material">Fig. S3B</xref>).</p><fig position="float" fig-type="figure" id="F2" orientation="portrait"><label>Fig 2</label><caption><p>Fluorescence-activated cell sorting (FACS) results from a 4DP assay of <italic toggle="yes">Plasmodium falciparum</italic> 803 parasites. An unsynchronized culture at 2% initial parasitemia was treated with 700 nM DHA for 6 h on days 0, 1, 2, and 3. Cells from culture samples were stained with SYBR Green I (SG) and MitoTracker Deep Red (MT) for FACS analysis and purification on days 2, 4, 9, 11, 14, 16, 18, and 23. (A&#8211;H) Left and right panels show the parasite distributions and gates for the two steps of FACS purification by a BD Aria fusion flow cytometer. Left panels indicate SYBR Green I (SG) and Side Scatter (SS) levels of SG<sup>+</sup> pRBC subjected to yield sorting. Right panels show the three gates delineating the MT dim (MT<sup>D</sup>), MT intermediate (MT<sup>I</sup>), and MT bright (MT<sup>B</sup>) assigned to the yield-sorted pRBC for final purity sorting.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="aac.00053-24.f002.jpg"><alt-text>Paired scatterplots depict FACS results for SG+ and MT+ populations from a 4DP 700 nM DHA recrudescence assay at days 2&#8211;23. Left and right panels from the different days show the SG and MT levels used for yield- and purity-sorting, respectively.</alt-text></graphic></fig><p>Prior to the second step of purity sorting, FACS analysis of the SG<sup>+</sup>/MT<sup>+</sup> cells obtained by yield-sorting showed that most uRBC had been removed from each sample, effectively enriching the pRBC population (<xref rid="F2" ref-type="fig">Fig. 2A through H</xref>, right panels). We assigned three gates to these pRBC for purity-sort collection and further analysis:</p><list list-type="order" id="list1"><list-item><p>MT<sup>D</sup> for pRBC with dim MT signals overlapping with the upper range of uRBC background fluorescence;</p></list-item><list-item><p>MT<sup>I</sup> for pRBC with intermediate MT signals extending from the upper boundary of uRBC fluorescence, including the P2 and P3 regions of persister and ring-stage fluorescence delineated by Micchelli et al. (<xref rid="B44" ref-type="bibr">44</xref>).</p></list-item><list-item><p>MT<sup>B</sup> for pRBC defined with bright fluorescence characteristic of trophozoites and schizonts.</p></list-item></list><p>In agreement with the findings from Giemsa-stained films and MACSQuant analysis (<xref rid="F1" ref-type="fig">Fig. 1</xref>; <xref rid="SuF1" ref-type="supplementary-material">Fig. S3</xref>), signals from persister cells on days 2&#8211;11 dominated in the MT<sup>D</sup> and MT<sup>I</sup> gates, with few or no signals detected in the MT<sup>B</sup> gate (<xref rid="F2" ref-type="fig">Fig. 2A through D</xref>, right panels). Beginning on day 11, we observed markedly decreased signals in the MT<sup>D</sup> gate relative to the steadier signal rate in the MT<sup>I</sup> gate and rising rate in MT<sup>B</sup> gate (<xref rid="F2" ref-type="fig">Fig. 2D through H</xref>, right panels). The decreases in the MT<sup>D</sup> gate and increases in the MT<sup>B</sup> gate from days 11 to 23 are consistent with declining numbers of persisters and concomitantly expanding populations of recrudescent RTS observed by microscopy (<xref rid="F1" ref-type="fig">Fig. 1</xref>).</p><p>Purity-sorted pRBC from the BD Aria Fusion flow cytometer were centrifuged onto microscope slides in a Cytospin 4 cytocentrifuge using EprediaCytofunnels fixed with 100% methanol and Giemsa-stained for microscopy. <xref rid="F3" ref-type="fig">Fig. 3A through H</xref> presents micrographs of the MT<sup>I</sup> parasites collected from 803 4DP, 700 nM DHA recrudescence assays at days 1, 2, 4, 7, 9, 11, 14, and 16. In these images, we observed persister forms, including types I and II but no circular-shaped ring forms until day 14 (<xref rid="F3" ref-type="fig">Fig. 3G</xref>). This finding of ring forms on day 14 was consistent with the rise of MT<sup>B</sup> parasites detected by FACS analysis (<xref rid="F2" ref-type="fig">Fig. 2E</xref>). Intraerythrocytic parasites with disorganized structures were often found during the second and third weeks of the assay (<xref rid="F3" ref-type="fig">Fig. 3D, F, G and H</xref>), consistent with the apicoplast heterogeneity and possible autophagy suggested in our previous study DHA/sorbitol-induced persisters (<xref rid="B44" ref-type="bibr">44</xref>).</p><fig position="float" fig-type="figure" id="F3" orientation="portrait"><label>Fig 3</label><caption><p>Giemsa-stained images of FACS-collected SG<sup>+</sup>/ MT<sup>I</sup>
<italic toggle="yes">P. falciparum</italic> 803 parasites selected by the 4DP protocol. The images are from Giemsa-stained monolayers obtained after Cytospin centrifugation. A range of persister forms is apparent, including Type I forms with a small, rounded nucleus and apparent cytoplasm (red arrows); and Type II forms with a rounded, intensely stained nucleus but little stained cytoplasm (gray arrows) (<xref rid="B45" ref-type="bibr">45</xref>). (<bold>A</bold>) Abundant large irregular parasites with crisis-like appearance are found in cytospin preparations on day 1. (<bold>D, F, G, H</bold>) Examples of cells appearing to have disorganized structures suggestive of autophagy are circled. (<bold>F, G</bold>) Recrudescent ring stages are indicated by blue arrows. Additional images from Giemsa-stained thin blood films are shown in <xref rid="SuF1" ref-type="supplementary-material">Fig. S2</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="aac.00053-24.f003.jpg"><alt-text>Microscopic images show Giemsa-stained P. falciparum 803 parasites treated by 4DP and collected by FACS on days 1&#8211;16. Various persisters, crisis-like forms, and ring stages are marked by arrows. Cells with faded and disorganized structure are circled.</alt-text></graphic></fig></sec><sec id="s2-3"><title>Transcription levels from genes encoding acetyl CoA carboxylase and skeleton-binding protein 1</title><p>Genes involved in fatty acid synthesis and pyruvate metabolism remain active after ART-induced dormancy in <italic toggle="yes">P. falciparum</italic>, suggesting their expression is vital to persister viability (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Chen et al. (<xref rid="B28" ref-type="bibr">28</xref>) examined the transcripts of genes, including PF3D7_1026900 (NCBI gene ID 8445054, identified as &#8220;<italic toggle="yes">acc</italic>&#8221; in Ref. [<xref rid="B28" ref-type="bibr">28</xref>] but encoding the biotin&#8211;protein ligase one paralog PfHCS1 [<xref rid="B49" ref-type="bibr">49</xref>]) and PF3D7_1469600 (NCBI gene ID 812246, encoding acetyl&#8211;CoA carboxylase with a sequence named <italic toggle="yes">bc</italic> in Refs. [<xref rid="B28" ref-type="bibr">28</xref>] and [<xref rid="B11" ref-type="bibr">11</xref>]). Results of that study showed that a single 6 h pulse of DHA increased transcription of PF3D7_1026900 and PF3D7_1469600 by 1.83- and 3.72-fold on day 2, respectively, after which transcription of these genes returned to baseline and lower levels on days 3&#8211;8.</p><p>Here, we follow the conventions of Goodman et al. (<xref rid="B50" ref-type="bibr">50</xref>) and Dellibovi-Ragheb et al. (<xref rid="B49" ref-type="bibr">49</xref>) and refer to the PF3D7_1469600 acetyl&#8211;CoA carboxylase gene as <italic toggle="yes">acc</italic>. Using qRT-PCR with the primers and probe identified in <xref rid="SuF1" ref-type="supplementary-material">Fig. S4</xref> and <xref rid="SuF1" ref-type="supplementary-material">Table S1</xref>, we compared the time course and levels of <italic toggle="yes">acc</italic> upregulation after DHA induction with a single 6 h pulse (1DP protocol). Results from this 1DP protocol showed <italic toggle="yes">acc</italic>/PF3D7_1469600 transcription increased by 2.88-fold at 6 h and 4.89-fold at 48 h post-treatment (<xref rid="SuF1" ref-type="supplementary-material">Fig. S5A</xref>).</p><p>Next, we assessed <italic toggle="yes">acc</italic> transcript levels during and after four daily 6 h pulses of 700 nM DHA in 4DP recrudescence assays. These confirmed a dynamic pattern of <italic toggle="yes">acc</italic> expression through dormancy and into recrudescence (<xref rid="F4" ref-type="fig">Fig. 4A</xref>). Initially, <italic toggle="yes">acc</italic> transcript levels decreased relative to untreated controls (0.6-fold on day 2, <italic toggle="yes">P</italic> = 0.03; 0.5-fold on day 4, <italic toggle="yes">P</italic> = 0.03). However, an upregulation occurred on day 7 (1.6-fold, <italic toggle="yes">P</italic> = 0.05), followed by a return to near-control levels on day 9 (1.1-fold; <italic toggle="yes">P</italic> = 0.23). After further decreases on days 11 and 14 (0.8-fold, <italic toggle="yes">P</italic> = 0.05 and 0.4-fold, <italic toggle="yes">P</italic> = 0.03, respectively), the <italic toggle="yes">acc</italic> transcript levels rose again (0.6-fold on day 16, <italic toggle="yes">P</italic> = 0.03; 0.9-fold on day 18, <italic toggle="yes">P</italic> = 0.35). After a dip at day 21 (0.6-fold, <italic toggle="yes">P</italic> = 0.05), the <italic toggle="yes">acc</italic> transcript levels returned to those of control parasites on day 23 (1.3-fold, <italic toggle="yes">P</italic> = 0.1).</p><fig position="float" fig-type="figure" id="F4" orientation="portrait"><label>Fig 4</label><caption><p>Relative levels of acetyl&#8211;CoA carboxylase (<italic toggle="yes">acc</italic>) and skeleton-binding protein 1 (<italic toggle="yes">sbp1</italic>) transcripts after 4DP exposures of <italic toggle="yes">P. falciparum</italic> 803 parasites to 700 nM dihydroartemisinin. (<bold>A</bold>) Relative levels of reverse-transcribed <italic toggle="yes">acc</italic> transcripts. (<bold>B</bold>) Relative levels of reverse-transcribed <italic toggle="yes">sbp1</italic> transcripts. qRT-PCR measurements were performed at the initiation of DHA treatment on day 0 (black vertical bar) and at indicated days thereafter (gray vertical bars). Data points represent means from three independent replicates, with error bars indicating standard deviations.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="aac.00053-24.f004.jpg"><alt-text>Bar graphs depict fold expression changes relative to the DMSO control over 23 days. Individual data points are depicted for each time point, with standard error bars representing variability across replicates.</alt-text></graphic></fig><p>We also evaluated transcript levels of <italic toggle="yes">sbp1</italic>, as expression of this gene after ACT treatment (<xref rid="B36" ref-type="bibr">36</xref><xref rid="B37" ref-type="bibr">&#8211;</xref><xref rid="B38" ref-type="bibr">38</xref>) may be consistent with a role in persister viability and replication upon recrudescence. After a single 6 h 700 nM DHA pulse in the 1DP protocol, <italic toggle="yes">sbp1</italic> was upregulated at 6 h (2.1-fold, <italic toggle="yes">P</italic> = 0.05) and 48 h (1.9-fold, <italic toggle="yes">P</italic> = 0.05) (<xref rid="SuF1" ref-type="supplementary-material">Fig. S5B</xref>). In the 4DP protocol, <italic toggle="yes">sbp1</italic> transcript levels on day 2 were increased 1.7-fold relative to the pretreatment level (<italic toggle="yes">P =</italic> 0.04) (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). The ratios then showed a declining trend to 1.3-fold on day 4 (<italic toggle="yes">P =</italic> 0.06), 0.7-fold on day 7 (<italic toggle="yes">P</italic> = 0.05), reaching 0.4-fold on day 14 (<italic toggle="yes">P</italic> = 0.03) before returning to near those of control parasites [0.9-fold on day 18, (<italic toggle="yes">P =</italic> 0.35); 1.2-fold on day 23, (<italic toggle="yes">P =</italic> 1.2)].</p></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>Exposing asynchronous <italic toggle="yes">P. falciparum</italic> cultures to multiple daily 6 h pulses of DHA provides a robust and efficient means for the production and study of dormant persisters. In the 3DP, as well as 4DP, protocols, actively replicating parasites were reliably transformed into persister populations when exposed to 200 or 700 nM DHA. Type II persisters characterized in Giemsa-stained cells by dark round or irregular-appearing nuclei and faded or no detectable cytoplasm, dominated in these populations, while Type I persisters containing rounded nuclei and readily detected cytoplasm were less frequently observed. Importantly, recrudescence of actively replicating parasites was consistently obtained in our protocols, with rings appearing in Cytospin preparations around 2 weeks after the initial DHA exposure. Using persisters purified by FACS after SG and MT staining, we found that transcripts from genes encoding <italic toggle="yes">acc</italic> and <italic toggle="yes">sbp1</italic> were differentially expressed along the timeline of persister induction, dormancy, and recrudescence, reflecting the metabolic changes enabling parasite survival and recovery (<xref rid="B28" ref-type="bibr">28</xref>). These findings highlight the remarkable ability of malaria parasites to survive drug exposure. Multi-DHA-pulse protocols will facilitate insights into the physiological states of persisters and the molecular processes of dormancy and recrudescence, potentially suggesting new strategies for drug development.</p><p>Protocols applying a single 6 h DHA pulse to synchronized rings typically use several daily rounds of follow-up magnetic column purification or sorbitol lysis to ensure the elimination of actively replicating parasites (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>). While effective, these methods have potential drawbacks. MACS column purification is costly and subjects cells to prolonged stress outside of culture conditions. Sorbitol treatments for parasite synchronization and/or follow-up removal of actively replicating parasites involve multiple manipulations that can induce dormancy independently (<xref rid="B21" ref-type="bibr">21</xref>), potentially confounding studies of dormancy induced by ART and other antimalarial drugs. In contrast, our 3DP and 4DP protocols, by applying multiple daily 200 or 700 nM DHA pulses to mixed parasite stages, transform and eliminate the actively replicating parasites without additional manipulations. This approach simplifies the prodecure, reduces potential confounding factors, and enhances the reliability of preparations for investigations of persister biology and drug resistance mechanisms.</p><p>Our study examined transcript levels from two key genes, acetyl CoA carboxylase (<italic toggle="yes">acc</italic>) and skeleton binding protein 1 (<italic toggle="yes">sbp1</italic>), which are implicated in persister viability after ART exposure (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B33" ref-type="bibr">33</xref><xref rid="B34" ref-type="bibr">&#8211;</xref><xref rid="B35" ref-type="bibr">35</xref>). Consistent with the report of Chen et al. (<xref rid="B28" ref-type="bibr">28</xref>), our 1DP protocol using a single 6 h DHA exposure showed 2.88-fold <italic toggle="yes">acc</italic> upregulation at 6 h and 4.89-fold upregulation at 48 h. However, with the 4DP protocol, we found 0.5&#8211;0.6-fold downregulation of <italic toggle="yes">acc</italic> transcript levels through day 4, then a bounce to 1.6-fold upregulation at day 7, before a steady decline to 0.3-fold at day 14. The use of four daily DHA treatments in the 4DP protocol may be responsible for later upregulation of <italic toggle="yes">acc</italic> transcription (on day 7) compared to the upregulation seen after the single DHA treatment in the 1DP protocol (on day 2). In both cases, <italic toggle="yes">acc</italic> upregulation after the completion of DHA exposure points to an important role of fatty acid synthesis in persister development before transcription falls to lower levels later in dormancy (<xref rid="B28" ref-type="bibr">28</xref>). The later day-7 peak of <italic toggle="yes">acc</italic> transcription after four daily DHA pulses compared to the day-2 peak after the single DHA pulse suggests that time course of dormancy induction can depend upon the number of drug pulses. Thus, depending upon the induction protocol, persister development or &#8216;maturation&#8217; may extend beyond the 5-day period that has been proposed after a single DHA pulse (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>Transcription levels of <italic toggle="yes">sbp1</italic>, a gene crucial for protein export and cytoadherence (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>), also exhibited dynamic changes during our 4DP experiments. Notably, <italic toggle="yes">sbp1</italic> transcripts were detected during days 2&#8211;9 when no active parasite stages were observed, suggesting origin of these transcripts from persisters. This result aligns with the continuing presence of <italic toggle="yes">sbp1</italic> signals found after ACT treatment of <italic toggle="yes">P. falciparum</italic> infections in clinical studies (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Distinct transcription patterns of <italic toggle="yes">acc</italic> and <italic toggle="yes">sbp1</italic> highlight the complex metabolic and cellular adaptations of persisters during dormancy and recovery.</p><p>In FACS preparations, MT<sup>+</sup>/SG<sup>+</sup> fluorescence was detected from both type I and II persisters throughout the dormancy period, indicating they maintained mitochondrial membrane potential, a key indicator of cellular viability, despite their morphological differences in Giemsa-stained thin film preparations. These findings complement super-resolution microscopy evidence showing that MT<sup>+</sup> mitochondria in the persisters enlarge and move into closer association with nuclei, potentially participating in retrograde signaling responses to stress (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B44" ref-type="bibr">44</xref>). Our observation of energetically functional mitochondria lasting for weeks in the whole SG<sup>+</sup> population challenges the notion that a large fraction of Type II/pyknotic-like persisters is dead. Instead, this evidence for intact mitochondria in the SG<sup>+</sup> population suggests that some metabolic processes may be sustained in Type II persisters during the dormancy period.</p><p>These experiments in this report were not designed to look for differences of time-to-recrudescence due to parasite genetic backgrounds, DHA exposure number in the 4DP and 3DP protocols, or other variations from factors such as shelf age or blood types of erythrocytes from different donors. In a previous study of PfK13 mutations and laboratory measures for ART resistance, we crossed the GB4 (PfK13 wild type) and 803 (carrying the PfK13 C580Y mutation) lines and examined the inherited genotypes and phenotypes of the parents and progeny (<xref rid="B17" ref-type="bibr">17</xref>). Although ring-stage survival assays (RSAs) of the parents and progeny confirmed linkage of the C580Y mutation to proportionally greater survival of ring stages to a 6 h pulse of 700 nM DHA, similar low nM IC<sub>50</sub> levels were found for all the parasites after exposure to DHA for 72 h. Data from artesunate-treated New World monkeys also showed no significant differences in the parasitemia clearance half-lives or recrudescences of the <italic toggle="yes">in vivo</italic> infections from the parasites carrying either a wild-type or C580Y-mutant PfK13. Further experiments were then performed to test for an effect of the C580Y on recrudescence <italic toggle="yes">in vitro</italic> using an isogenic pair of clones engineered to differ only by this mutation (76H10<sup>580Y</sup> and 76H10<sup>C580</sup>). In replicate head-to-head comparisons, recrudescences of the 76H10<sup>580Y</sup> parasites (nominally &#8216;resistant&#8217; by RSAs) occurred no sooner than those of the isogenic 76H10<sup>C580</sup> parasites (&#8216;sensitive&#8217; by RSAs; see supplemental Fig. S8 of S&#225; et al. [<xref rid="B17" ref-type="bibr">17</xref>]). These findings agreed with those of Breglio et al. (<xref rid="B39" ref-type="bibr">39</xref>) who examined a different set of isogenic lines and found no association of Kelch mutations C580Y or R539T to <italic toggle="yes">in vitro</italic> recrudescence times, whereas parasites of different backgrounds showed differences suggesting possible effects from other, perhaps multiple genetic determinants.</p><p>In a recent study of persisters after DHA/sorbitol treatment (<xref rid="B44" ref-type="bibr">44</xref>), we found progressive heterogeneity of enlarged and irregularly shaped apicoplasts as the persisters aged. These results suggested that apicoplasts may be subject to autophagic processes analogous to the processes of chlorophagy found after chloroplast swelling, vesiculation, and degradation from ROS damage in plants (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>). Here, we provide two additional findings that lend further credence to the suggestion of autophagy in persisters. First, Giemsa-stained images of Type II persisters in the MT<sup>+</sup> populations purified by FACS showed minimal (&#8220;faded&#8221;) or no stained cytoplasm. This lack of stained cytoplasm in Type II images agrees with findings of &#8220;vacant cytoplasm&#8221; associated with enlarged mitochondria, reduced ribosomes, and multi-membrane structures in the transmission electron micrographs of persisters reported by Tripathi et al. (<xref rid="B29" ref-type="bibr">29</xref>). Second, cells with disorganized structure were present in our Cytospin preparations of MT<sup>+</sup> persisters at the second and third weeks of dormancy. The MT positivity of these cells is more consistent with autophagy than with cell death by primary apoptosis or necrosis as these latter two processes typically show early loss of mitochondrial function (<xref rid="B55" ref-type="bibr">55</xref>).</p><p>Autophagy has been previously implicated in <italic toggle="yes">P. falciparum</italic> blood stages stressed by nutrient starvation or exposure to various toxins and drugs, including chloroquine (<xref rid="B56" ref-type="bibr">56</xref><xref rid="B57" ref-type="bibr">&#8211;</xref><xref rid="B59" ref-type="bibr">59</xref>). While features of apoptosis or necrosis have been proposed from other studies of cell death phenotypes (<xref rid="B60" ref-type="bibr">60</xref>), autophagy may be key to the interior cellular remodelings necessary for metamorphosis of <italic toggle="yes">P. falciparum</italic> into various stages, such as gametocytes and liver stage parasites (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>). Moreover, the autophagy homolog PfATG8 is vital to apicoplast formation and has been suggested to have roles in both degradative and biosynthetic processes in the cell (<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B63" ref-type="bibr">63</xref><xref rid="B64" ref-type="bibr">&#8211;</xref><xref rid="B65" ref-type="bibr">65</xref>). Given these observations and the various non-autophagic roles of ATG-related proteins (<xref rid="B66" ref-type="bibr">66</xref>), we speculate that autophagy or autophagic-like processes may be involved in <italic toggle="yes">P. falciparum</italic> persister survival and viability under stress. As in the metamorphosis of other <italic toggle="yes">P. falciparum</italic> stages, autophagic-like processes may also facilitate the remodeling events necessary to transform blood-stage parasites into persisters and later return these persisters to actively replicating forms for recrudescence.</p><p>While multiple studies have implicated persisters in recrudescence after DHA-induced dormancy, the origin of actively replicating recrudescent parasites remains to be definitively demonstrated. Recrudescence in culture showed little or no delay after persister populations were exposed for 1 day to pyrimethamine (1&#8211;100&#215; IC<sub>50</sub>), making it seem unlikely that a low number of ring stages remains active through the period of DHA treatment and exponentially replicates to produce the recrudescent population (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B67" ref-type="bibr">67</xref>). Caveats to this conclusion include: the growth of rings and trophozoites was found to be unaffected when treated with 100&#215; IC<sub>50</sub> pyrimethamine concentrations for 24 h (<xref rid="B68" ref-type="bibr">68</xref>); and asynchronous <italic toggle="yes">P. falciparum</italic> cultures predominantly containing ring stages required 53&#8211;55 h to effectively clear when exposed to daily concentrations of 3&#215;, 10&#215;, or 100&#215; IC<sub>50</sub> pyrimethamine (<xref rid="B69" ref-type="bibr">69</xref>). In other studies, various antimalarial compounds have been shown to delay recrudescences <italic toggle="yes">in vitro</italic>, suggesting these compounds can remain partially toxic to persisters despite their relatively quiescent state (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B67" ref-type="bibr">67</xref>). Findings of persisters after ART treatment in mice infected with <italic toggle="yes">P. vinckei</italic> (<xref rid="B15" ref-type="bibr">15</xref>), humans infected with <italic toggle="yes">P. falciparum</italic> (<xref rid="B11" ref-type="bibr">11</xref>), <italic toggle="yes">Aotus</italic> monkeys infected with <italic toggle="yes">P. falciparum</italic> (<xref rid="B17" ref-type="bibr">17</xref>), and <italic toggle="yes">Saimiri boliviensis</italic> monkeys infected with <italic toggle="yes">P. vivax</italic> (<xref rid="SuF1" ref-type="supplementary-material">Fig. S6</xref>) provide further support for the role of these parasite forms in recrudescent infections. In all of these observations, the persisters have featured Giemsa-stained cytoplasm characteristic of Type I morphology. Cytoplasm that has not been hollowed out by autophagy may thus be necessary to power persister remodeling and transformation. Confirmation of this hypothesis may be feasible by isolating the different types of persister stages (I vs. II) and directly studying them for autophagy and reactivation into replicating stages.</p><p>The protocols described in this report offer robust and efficient means to prepare pure <italic toggle="yes">P. falciparum</italic> persister populations induced by ART without the expense of magnetic columns, exposure to sorbitol, or prolonged manipulations of previous approaches. These protocols will be valuable for investigating the molecular mechanisms underlying ART-induced dormancy and parasite recrudescence. The evidence for mitochondrial activity and apicoplast heterogeneity in persisters, along with the observed patterns of <italic toggle="yes">acc</italic> and <italic toggle="yes">sbp1</italic> expression, highlight the complex metabolic and structural adaptations underlying the generation of dormant forms and their reactivation. Autophagic-like processes may play a vital role both in maintaining persister viability and facilitating parasite remodeling for dormancy and recrudescence. Future investigations employing methods, such as RNA sequencing and metabolomics, on purified type I and II persister populations will help to elucidate the pathways by which parasites enter dormancy, maintain the dormant state, and reactivate to normal proliferation. These insights will help to identify novel targets and suggest therapeutics to interrupt these processes, potentially preventing parasite recrudescence. By enhancing our understanding of persister biology, this research will lay the foundation for more effective strategies to combat ACT failures and improve malaria treatment outcomes.</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4-1"><title><italic toggle="yes">Plasmodium falciparum</italic> parasites, culture maintenance, and microscopy of Giemsa-stained thin films</title><p><italic toggle="yes">P. falciparum</italic> 803 from Cambodia (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B70" ref-type="bibr">70</xref>) and GB4 from Ghana (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>) were cultured in leucocyte-depleted human O<sup>+</sup> erythrocytes (RBC; Interstate Blood Bank, Inc., Memphis, Tennessee) in complete RPMI (cRPMI) medium. The cRPMI consisted of RPMI 1640 medium (KD Medical, Cat. No. CUS-0645, Columbia, MD) supplemented with 25 mM HEPES, 50 &#181;g/mL hypoxanthine, 0.21% NaHCO<sub>3</sub> (KD Medical, Cat. No. RGC-5120, Columbia, MD), 20 &#181;g/mL gentamycin (KD Medical, Cat. No. CAG-1240, Columbia, MD), and 1% (wt/vol) AlbuMAX II (Gibco Cat. no 11021-045). Parasite cultures were maintained at 5% hematocrit at 37&#176;C under an atmosphere of 90% nitrogen, 5% oxygen, and 5% carbon dioxide.</p><p>For microscopy, thin films of the cells were prepared on glass slides, fixed with 100% methanol for 5 s, and air-dried in a dust-free environment. The slides were then stained by immersion for 30 min in a 25% Giemsa solution (Sigma-Aldrich, St. Louis, MO) prepared using Milli-Q purified water (Millipore Sigma, USA). After staining, the slides were rinsed with Milli-Q water and air-dried before microscopic examination using an Olympus CX41 microscope with a 100&#215; oil immersion objective. Images of the stained cells were acquired using a camera and Infinity Analyze Software (ACCU-SCOPE version 7.1.0). Two to four experienced microscopists blinded to slide identification independently assessed 1,000 RBCs from each thin film for the percentage calculations of rings, trophozoites, schizonts, crisis-like forms, and type I or II persisters. Statistical analyses of the parasitemia counts were performed using GraphPad Prism 9 software (GraphPad Software, San Diego, CA).</p></sec><sec id="s4-2"><title>Recrudescences and sample collection from DHA-treated parasites <italic toggle="yes">in vitro</italic></title><p>Unsynchronized parasites were established in 10 or 15 mL culture volumes at 2% parasitemia and 5% hematocrit. These were exposed to 6 h daily pulses of dihydroartemisinin (DHA; &#8805;97% (TLC) purity, Sigma Aldrich, Cat. No. D7439, USA) at concentrations of 200, 400, or 700 nM in cRPMI. DHA stock solutions were prepared in dimethyl sulfoxide (DMSO; &#8805;99.9% purity, Sigma Aldrich, Cat. No. 276855, USA) and diluted in cRPMI such that the final medium contained &#8804;0.1% residual DMSO. For each experiment, a parallel 15 mL culture was established from the same master culture and exposed to 0.1% DMSO without DHA as a vehicle control.</p><p>After each 6 h DHA or vehicle control exposure, the cells were washed twice with 10 or 15 mL of pre-warmed cRPMI, centrifuged at 2,500 rpm for 5 min in a bench-top centrifuge (Eppendorf Centrifuge 5810) at room temperature, resuspended in 10 or 15 mL cRPMI, and returned to culture. To maintain hematocrit and prevent potential hemolysis, 100 &#181;L of freshly washed RBC [50% hematocrit in incomplete RPMI (iRPMI)] medium were added every 7 days. The iRPMI was composed of RPMI 1640 medium (KD Medical, Cat. No. CUS-0645, Columbia, MD) supplemented with 25 mM HEPES, 50 &#181;g/mL hypoxanthine, 0.21% NaHCO<sub>3</sub> (KD Medical, Cat. No. RGC-5120, Columbia, MD), and 20 &#181;g/mL gentamycin (KD Medical, Cat. No. CAG-1240, Columbia, MD). On selected days (indicated in the Results section), 100 &#181;L samples from each culture suspension were collected for parasite counts from Giemsa-stained thin smears and flow cytometry analysis; 1 mL samples were used for fluorescence-activated cell sorting (FACS) collections as described below. Culture medium was changed daily during DHA treatment and every 2 days thereafter. Vehicle control cultures containing actively replicating parasites were diluted 1:10 when parasitemia exceeded 2%</p></sec><sec id="s4-3"><title>Flow cytometry analysis</title><p>A 100 &#181;L volume from each culture was centrifuged at 2,500 rpm for 30 s in a bench-top centrifuge (Eppendorf model 5417R) at room temperature, and the pelleted cells were resuspended to 190 &#181;L in wash buffer (1&#215; Hanks&#8217; balanced salt solution; Gibco, Cat. No. 14025092, Waltham, MA) containing 2% fetal bovine serum (Gibco, Cat. No. 26140079, Waltham, MA). To stain the parasitized erythrocytes (pRBC), 8 &#181;L of stock SYBR Green I (5 &#215; SG from 10,000&#215; concentrate in DMSO; Invitrogen, Cat. no S7585, USA) and 2 &#181;L of stock 7.5 &#181;M MitoTracker Deep Red (MT, Thermo Fischer Scientific, Cat. no <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="M22426">M22426</ext-link>, USA) were added to the 190 &#181;L suspension, resulting in final concentrations of 0.2&#215; SG and 75 nM MT. The suspension was then incubated at 37&#176;C for 30 min in the dark. After staining, the cells were washed twice with wash buffer with centrifugation at 2,500 rpm for 3 min in a bench-top centrifuge (Beckman Coulter model Allegra x-14R). The pellet was resuspended in 500 &#181;L of wash buffer for flow cytometry using a MACSQuant Analyzer model 10 (Miltenyi Biotec) using the 488 nm laser excitation and a 525/50 nm bandpass filter for SG fluorescence emission detection and 640 nm excitation and a 665&#8211;730 nm bandpass filter for MT fluorescence detection. Photomultiplier tube voltages were set to 350 V for forward scatter, 300 V for side scatter, 500 V for SG, and 450 V for MT.</p><p>Unstained and stained uninfected erythrocytes (uRBC) were used for calibration and compensation. At least 1 million cells per sample were counted to quantify the fluorescent cells. Flow cytometer data were processed using MACSQuantify Software (version 2.13.3, Miltenyi Biotec).</p></sec><sec id="s4-4"><title>Fluorescence-activated cell sorting (FACS) and collection of SG<sup>+</sup>/MT<sup>+</sup> cells</title><p>Cells were collected from 1 mL volumes of culture suspensions, washed twice with wash buffer, resuspended to 190 &#181;L, and stained with SG and MT, as described above. An Aria Fusion flow cytometer (BD Biosciences) was used to obtain data from at least 1 million events. Analysis was performed with BD FACSDiva Software 9.0 (BD Biosciences, San Jose, CA). Cells were sorted in two steps as recommended by BD Biosciences. In the first step, high-throughput yield sorting for SG<sup>+</sup> pRBC was performed with 488 nm laser excitation and detection of fluorescence emission with a 530/30 nm bandpass filter. In the second step, the enriched SG<sup>+</sup> pRBC from the first step were analyzed and further separated by purity sorting using both the 488 nm laser excitation and detection of fluorescence emission with a 530/30 nm bandpass filter, as well as the 637 nm laser excitation and detection of MT fluorescence emission at 670/30 nm bandpass filter. The SG<sup>+</sup>/MT<sup>+</sup> pRBC were collected into or cRPMI through the MT Dim (MT<sup>D</sup>), MT Intermediate (MT<sup>I</sup>), and MT Bright (MT<sup>B</sup>) gates described in the Results section.</p><p>For Cytospin preparations, &#8805;50,000 purity-sorted SG<sup>+</sup>/MT<sup>+</sup> pRBC were centrifuged at 8,000 rpm for 2 min in an Eppendorf centrifuge (Model 5810) at room temperature, and the pellet was resuspended in 100 &#181;L of wash buffer or cRPMI. The suspension was dispensed onto an Epredia Cytofunnel (Fisher Scientific, Cat. No. 59-910-40, USA) with a mounted microscope slide. After centrifugation at 500 rpm (28 g) for 5 min in a Cytospin 4 Cytocentrifuge (Epredia), the pRBC monolayer was fixed with 100% methanol, air-dried for 10 min, and stained with 25% Giemsa solution for 30 min as described above. Microscope images of the stained cells were captured with an Olympus CX41 fitted with a camera using a 100-oil immersion objective lens and Infinity Analyze Software (ACCU-SCOPE version 7.1.0).</p></sec><sec id="s4-5"><title>Determination of acetyl CoA carboxylase (<italic toggle="yes">acc</italic>) and skeleton-binding protein 1 (<italic toggle="yes">sbp1</italic>) transcript levels</title><p>On the selected follow-up days, 250,000 purity-sorted SG<sup>+</sup>/MT<sup>I</sup> pRBC were collected from each culture, and cDNA was synthesized using the SuperScript IV Cells Direct Kit (Invitrogen, Cat. No. 11750150) according to the manufacturer&#8217;s instructions. DNase I treatment was performed during cell lysis to ensure the synthesized cDNA was free of genomic DNA contamination.</p><p>All the primers and probes (<xref rid="SuF2" ref-type="supplementary-material">File S2</xref>) were designed on Benchling (San Francisco, CA; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.benchling.com/" ext-link-type="uri">https://www.benchling.com/</ext-link>), and parameters were confirmed using OligoCalc (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bio.tools/oligocalc" ext-link-type="uri">https://bio.tools/oligocalc</ext-link>) and by BLAST search on PlasmoDB (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://plasmodb.org/plasmo/app" ext-link-type="uri">https://plasmodb.org/plasmo/app</ext-link>). To increase specificity and reduce background fluorescence, all qRT-PCR assays were carried out using the double-quenched hydrolysis probes consisting of 5&#8242; FAM, fluorophores, and a 3' Iowa Black FQ quencher with an additional secondary internal quencher, IDT ZEN (Integrated DNA Technologies, Coralville, IA). The working solution for each primer was 10 pmol/&#181;L, and the hydrolysis probe was constituted to 5 pmol/&#181;L. For a 25 &#181;L PCR reaction mix, 10 &#181;L of PrimeTime Gene Expression Master Mix (IDT, Cat. No. 1055770) was mixed with 2 &#181;L forward primer (final concentration 0.8 &#181;M), 2 &#181;L reverse primer (0.8 &#181;M), 2 &#181;L hydrolysis probe (0.4 &#181;M), 4 &#181;L of PCR water, and 5 &#181;L of the synthesized cDNA solution. The qRT-PCR was performed on a CFX Connect Real-time PCR Detection System (Bio-Rad, USA) for 45 cycles of 95&#176;C for 10 s, 59&#176;C for 30 s, and 72&#176;C for 30 s. After the final cycle, the reaction mix was held at 4&#176;C. Three technical replicates of transcript levels were measured from each of three different biological replicates (3 &#215; 3 = 9 measurements).</p><p>Transcription levels of <italic toggle="yes">acc</italic> and <italic toggle="yes">sbp1</italic> were determined on selected assay days relative to day 0 baseline before the first drug exposure. Each gene&#8217;s average quantification cycle (Cq) values were calculated from triplicate wells. Due to the known downregulation of the common reference genes for serine tRNA ligase (<italic toggle="yes">sars</italic>) (PF3D7_0717700) and lactate dehydrogenase (<italic toggle="yes">ldh</italic>) (PF3D7_1324900) in parasites exposed to DHA (<xref rid="B28" ref-type="bibr">28</xref>), we used a standard curve generated from genomic DNA (gDNA) to quantify the mRNA transcripts of <italic toggle="yes">acc</italic> (PF3D7_1469600) and <italic toggle="yes">sbp1</italic> (PF3D7_0501300) as described by Gray et al. (<xref rid="B27" ref-type="bibr">27</xref>). Specifically, gDNA from tightly synchronized ring stage parasites (0&#8211;6 h) was serially diluted from 5 to 0.04 ng/&#956;L, confirmed for concentration using a DS-11 series spectrophotometer (DeNovix, Wilmington, USA), and subjected to qRT-PCR as described above. The average Cq values were used to generate a standard curve of gDNA concentration versus average Cq values. This standard curve was then employed to estimate the cDNA concentrations at different time points during and after DHA treatment. Fold change was calculated from a ratio of average Cq values of the treated group on each day to the untreated DMSO control. All statistical analyses were performed using GraphPad Prism 9.3.1 (Dotmatics) using the Mann&#8211;Whitney nonparametric test with a <italic toggle="yes">p</italic>-value set at 0.05 for significance.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. D.K. is a visiting fellow supported by the African Postdoctoral Training Initiative at the National Institute of Allergy and Infectious Diseases, Maryland.</p><p>Conceptualization and design of the study: D.K., J.M.S., J.M., and T.E.W. Performed experiments and/or analyzed data: D.K., J.M.S., A.K., C.E.M., S.N.A., A.G.B., S.A.A., B.X., L.A.M., N.M.O., C.M.P., J.M., and T.E.W. Wrote the manuscript and drafted the figures: D.K. and T.E.W. Revised and approved the final version: all authors.</p></ack><sec sec-type="data-availability" id="s5-1"><title>DATA AVAILABILITY</title><p>Spreadsheets of the primary data collected in this study are provided in the supplemental material.</p></sec><sec sec-type="supplementary-material" id="s5-2"><title>SUPPLEMENTAL MATERIAL</title><p specific-use="print-only">The following material is available online at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1128/aac.00053-24" ext-link-type="uri">https://doi.org/10.1128/aac.00053-24</ext-link>.</p><supplementary-material id="SuF1" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1128/aac.00053-24.SuF1</object-id><label>File S1</label><caption><title>aac.00053-24-s0001.pdf</title><p>Table S1; Figures S1 to S6.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="aac.00053-24-s0001.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="SuF2" position="float" content-type="local-data" orientation="portrait"><object-id pub-id-type="doi">10.1128/aac.00053-24.SuF2</object-id><label>File S2</label><caption><title>aac.00053-24-s0002.xlsx</title><p>Spreadsheets of data and analyses represented in Fig. 1, 4, and S5.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="aac.00053-24-s0002.xlsx" position="float" orientation="portrait"/></supplementary-material><p specific-use="online-only">ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse. </p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <year>2023</year>. <source>WHO Guidelines for Malaria</source>. <comment>Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.malariaworld.org/blogs/who-guidelines-for-malaria-16-october-2023" ext-link-type="uri">https://www.malariaworld.org/blogs/who-guidelines-for-malaria-16-october-2023</ext-link></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bunnag</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Viravan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Looareesuwan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Karbwang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Harinasuta</surname><given-names>T</given-names></string-name></person-group>. <year>1991</year>. <article-title>Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria</article-title>. <source>Southeast Asian J Trop Med Public Health</source><volume>22</volume>:<fpage>539</fpage>&#8211;<lpage>543</lpage>.<pub-id pub-id-type="pmid">1820641</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Looareesuwan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Viravan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Vanijanonta</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wilairatana</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Suntharasamai</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Charoenlarp</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Arnold</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Canfield</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Webster</surname><given-names>K</given-names></string-name></person-group>. <year>1992</year>. <article-title>Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria</article-title>. <source>Lancet</source><volume>339</volume>:<fpage>821</fpage>&#8211;<lpage>824</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0140-6736(92)90276-9</pub-id><pub-id pub-id-type="pmid">1347854</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nguyen</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Dao</surname><given-names>BH</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>PD</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>VH</given-names></string-name>, <string-name name-style="western"><surname>Le</surname><given-names>NB</given-names></string-name>, <string-name name-style="western"><surname>Mai</surname><given-names>VS</given-names></string-name>, <string-name name-style="western"><surname>Meshnick</surname><given-names>SR</given-names></string-name></person-group>. <year>1993</year>. <article-title>Treatment of malaria in Vietnam with oral artemisinin</article-title>. <source>Am J Trop Med Hyg</source><volume>48</volume>:<fpage>398</fpage>&#8211;<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.1993.48.398</pub-id><pub-id pub-id-type="pmid">8470777</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>GQ</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>XB</given-names></string-name>, <string-name name-style="western"><surname>Fu</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Jian</surname><given-names>HX</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>XH</given-names></string-name></person-group>. <year>1994</year>. <article-title>Clinical trials of artemisinin and its derivatives in the treatment of malaria in China</article-title>. <source>Trans R Soc Trop Med Hyg</source><volume>88 Suppl 1</volume>:<fpage>S5</fpage>&#8211;<lpage>6</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0035-9203(94)90460-x</pub-id><pub-id pub-id-type="pmid">8053027</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hoshen</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Na-Bangchang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Stein</surname><given-names>WD</given-names></string-name>, <string-name name-style="western"><surname>Ginsburg</surname><given-names>H</given-names></string-name></person-group>. <year>2000</year>. <article-title>Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of &#8220;dormancy&#8221;, a partial cytostatic effect of the drug, and its implication for treatment regimens</article-title>. <source>Parasitology</source><volume>121 ( Pt 3)</volume>:<fpage>237</fpage>&#8211;<lpage>246</lpage>. doi:<pub-id pub-id-type="doi">10.1017/s0031182099006332</pub-id><pub-id pub-id-type="pmid">11085244</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Teuscher</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Peters</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name></person-group>. <year>2010</year>. <article-title>Artemisinin&#8208;induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure</article-title>. <source>J Infect Dis</source><volume>202</volume>:<fpage>1362</fpage>&#8211;<lpage>1368</lpage>. doi:<pub-id pub-id-type="doi">10.1086/656476</pub-id><pub-id pub-id-type="pmid">20863228</pub-id><pub-id pub-id-type="pmcid">PMC2949454</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Codd</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Teuscher</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></string-name></person-group>. <year>2011</year>. <article-title>Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failure</article-title>. <source>Malar J</source><volume>10</volume>:<elocation-id>56</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/1475-2875-10-56</pub-id><pub-id pub-id-type="pmid">21385409</pub-id><pub-id pub-id-type="pmcid">PMC3060839</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></string-name></person-group>. <year>2012</year>. <article-title>Artemisinin resistance in Plasmodium falciparum: a process linked to dormancy?</article-title><source>Int J Parasitol Drugs Drug Resist</source><volume>2</volume>:<fpage>249</fpage>&#8211;<lpage>255</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpddr.2012.01.001</pub-id><pub-id pub-id-type="pmid">23420506</pub-id><pub-id pub-id-type="pmcid">PMC3572751</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peatey</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Chavchich</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Gresty</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Gray</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Waters</surname><given-names>NC</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name></person-group>. <year>2015</year>. <article-title>Mitochondrial membrane potential in a small subset of artemisinin-induced dormant Plasmodium falciparum parasites in vitro</article-title>. <source>J Infect Dis</source><volume>212</volume>:<fpage>426</fpage>&#8211;<lpage>434</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiv048</pub-id><pub-id pub-id-type="pmid">25635122</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peatey</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Gresty</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Pickering</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Watts</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>McCarthy</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name></person-group>. <year>2021</year>. <article-title>Dormant Plasmodium falciparum parasites in human infections following artesunate therapy</article-title>. <source>J Infect Dis</source><volume>223</volume>:<fpage>1631</fpage>&#8211;<lpage>1638</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/jiaa562</pub-id><pub-id pub-id-type="pmid">32901248</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wellems</surname><given-names>TE</given-names></string-name>, <string-name name-style="western"><surname>S&#225;</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>X-Z</given-names></string-name>, <string-name name-style="western"><surname>Connelly</surname><given-names>SV</given-names></string-name>, <string-name name-style="western"><surname>Ellis</surname><given-names>AC</given-names></string-name></person-group>. <year>2020</year>. <article-title>&#8220;Artemisinin resistance&#8221;: something new or old? something of a misnomer?</article-title><source>Trends Parasitol</source><volume>36</volume>:<fpage>735</fpage>&#8211;<lpage>744</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pt.2020.05.013</pub-id><pub-id pub-id-type="pmid">32586776</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ittarat</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Pickard</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Rattanasinganchan</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wilairatana</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Looareesuwan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Emery</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Low</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Udomsangpetch</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Meshnick</surname><given-names>SR</given-names></string-name></person-group>. <year>2003</year>. <article-title>Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors</article-title>. <source>Am J Trop Med Hyg</source><volume>68</volume>:<fpage>147</fpage>&#8211;<lpage>152</lpage>.<pub-id pub-id-type="pmid">12641403</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dondorp</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Nosten</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Yi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Das</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Phyo</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Tarning</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lwin</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Ariey</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Hanpithakpong</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Ringwald</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Silamut</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Imwong</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chotivanich</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Herdman</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>An</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Yeung</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Singhasivanon</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Day</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Lindegardh</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Socheat</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>NJ</given-names></string-name></person-group>. <year>2009</year>. <article-title>Artemisinin resistance in Plasmodium falciparum malaria</article-title>. <source>N Engl J Med</source>:<fpage>455</fpage>&#8211;<lpage>467</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa0808859</pub-id><pub-id pub-id-type="pmid">19641202</pub-id><pub-id pub-id-type="pmcid">PMC3495232</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>LaCrue</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Scheel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kennedy</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></string-name></person-group>. <year>2011</year>. <article-title>Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model Plasmodium vinckei</article-title>. <source>PLoS ONE</source><volume>6</volume>:<elocation-id>e26689</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0026689</pub-id><pub-id pub-id-type="pmid">22039533</pub-id><pub-id pub-id-type="pmcid">PMC3200358</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Meshnick</surname><given-names>S</given-names></string-name></person-group>. <year>2012</year>. <article-title>Perspective: artemisinin-resistant malaria and the wolf</article-title>. <source>Am J Trop Med Hyg</source><volume>87</volume>:<fpage>783</fpage>&#8211;<lpage>784</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.2012.12-0388</pub-id><pub-id pub-id-type="pmid">23136171</pub-id><pub-id pub-id-type="pmcid">PMC3516250</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>S&#225;</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kaslow</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Krause</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Melendez-Muniz</surname><given-names>VA</given-names></string-name>, <string-name name-style="western"><surname>Salzman</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Kite</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Moraes Barros</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Mu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>PK</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2018</year>. <article-title>Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>115</volume>:<fpage>12513</fpage>&#8211;<lpage>12518</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1813386115</pub-id><pub-id pub-id-type="pmid">30455312</pub-id><pub-id pub-id-type="pmcid">PMC6298093</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fisher</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Gollan</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Helaine</surname><given-names>S</given-names></string-name></person-group>. <year>2017</year>. <article-title>Persistent bacterial infections and persister cells</article-title>. <source>Nat Rev Microbiol</source><volume>15</volume>:<fpage>453</fpage>&#8211;<lpage>464</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro.2017.42</pub-id><pub-id pub-id-type="pmid">28529326</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vallette</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Olivier</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>L&#233;zot</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Oliver</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cochonneau</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Lalier</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cartron</surname><given-names>PF</given-names></string-name>, <string-name name-style="western"><surname>Heymann</surname><given-names>D</given-names></string-name></person-group>. <year>2019</year>. <article-title>Dormant, quiescent, tolerant and persister cells: four synonyms for the same target in cancer</article-title>. <source>Biochem Pharmacol</source><volume>162</volume>:<fpage>169</fpage>&#8211;<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bcp.2018.11.004</pub-id><pub-id pub-id-type="pmid">30414937</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McDonald</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Owusu-Ansah</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ellenbogen</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Malone</surname><given-names>ZD</given-names></string-name>, <string-name name-style="western"><surname>Ricketts</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Frolking</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Ernakovich</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Ibba</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bagby</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Weissman</surname><given-names>JL</given-names></string-name></person-group>. <year>2024</year>. <article-title>What is microbial dormancy?</article-title><source>Trends Microbiol</source><volume>32</volume>:<fpage>142</fpage>&#8211;<lpage>150</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tim.2023.08.006</pub-id><pub-id pub-id-type="pmid">37689487</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nakazawa</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kanbara</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Aikawa</surname><given-names>M</given-names></string-name></person-group>. <year>1995</year>. <article-title>Plasmodium falciparum: recrudescence of parasites in culture</article-title>. <source>Exp Parasitol</source><volume>81</volume>:<fpage>556</fpage>&#8211;<lpage>563</lpage>. doi:<pub-id pub-id-type="doi">10.1006/expr.1995.1149</pub-id><pub-id pub-id-type="pmid">8542997</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Teuscher</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name></person-group>. <year>2012</year>. <article-title>Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition</article-title>. <source>Antimicrob Agents Chemother</source><volume>56</volume>:<fpage>428</fpage>&#8211;<lpage>431</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.05456-11</pub-id><pub-id pub-id-type="pmid">21986828</pub-id><pub-id pub-id-type="pmcid">PMC3256014</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nakazawa</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Maoka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Uemura</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ito</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kanbara</surname><given-names>H</given-names></string-name></person-group>. <year>2002</year>. <article-title>Malaria parasites giving rise to recrudescence in vitro</article-title>. <source>Antimicrob Agents Chemother</source><volume>46</volume>:<fpage>958</fpage>&#8211;<lpage>965</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.46.4.958-965.2002</pub-id><pub-id pub-id-type="pmid">11897575</pub-id><pub-id pub-id-type="pmcid">PMC127107</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thapar</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Gil</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Bj&#246;rkman</surname><given-names>A</given-names></string-name></person-group>. <year>2005</year>. <article-title>In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil</article-title>. <source>Trans R Soc Trop Med Hyg</source><volume>99</volume>:<fpage>62</fpage>&#8211;<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.trstmh.2004.01.016</pub-id><pub-id pub-id-type="pmid">15550263</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ursing</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Johns</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Aydin-Schmidt</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Cal&#231;ada</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kofoed</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Ghanchi</surname><given-names>NK</given-names></string-name>, <string-name name-style="western"><surname>Veiga</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Rombo</surname><given-names>L</given-names></string-name></person-group>. <year>2022</year>. <article-title>Chloroquine-susceptible and -resistant Plasmodium falciparum strains survive high chloroquine concentrations by becoming dormant but are eliminated by prolonged exposure</article-title>. <source>J Antimicrob Chemother</source><volume>77</volume>:<fpage>1005</fpage>&#8211;<lpage>1011</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkac008</pub-id><pub-id pub-id-type="pmid">35137072</pub-id><pub-id pub-id-type="pmcid">PMC8969533</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nakazawa</surname><given-names>S</given-names></string-name></person-group>. <year>2005</year>. <article-title>Plasmodium berghei NK65: studies on the effect of treatment duration and inoculum size on recrudescence</article-title>. <source>Exp Parasitol</source><volume>111</volume>:<fpage>59</fpage>&#8211;<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.exppara.2005.05.002</pub-id><pub-id pub-id-type="pmid">15961077</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gray</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Gresty</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Gutteridge</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Peatey</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Chavchich</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Waters</surname><given-names>NC</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name></person-group>. <year>2016</year>. <article-title>Correlation between cyclin dependent kinases and artemisinin-induced dormancy in Plasmodium falciparum in vitro</article-title>. <source>PLoS ONE</source><volume>11</volume>:<elocation-id>e0157906</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0157906</pub-id><pub-id pub-id-type="pmid">27326764</pub-id><pub-id pub-id-type="pmcid">PMC4915707</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>LaCrue</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Teuscher</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Waters</surname><given-names>NC</given-names></string-name>, <string-name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Q</given-names></string-name></person-group>. <year>2014</year>. <article-title>Fatty acid synthesis and pyruvate metabolism pathways remain active in dihydroartemisinin-induced dormant ring stages of Plasmodium falciparum</article-title>. <source>Antimicrob Agents Chemother</source><volume>58</volume>:<fpage>4773</fpage>&#8211;<lpage>4781</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.02647-14</pub-id><pub-id pub-id-type="pmid">24913167</pub-id><pub-id pub-id-type="pmcid">PMC4135995</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tripathi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Stoklasa</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nayak</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>En Low</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Qian Hui Lee</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Duong Tien</surname><given-names>QH</given-names></string-name>, <string-name name-style="western"><surname>R&#233;nia</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Malleret</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Bozdech</surname><given-names>Z</given-names></string-name></person-group>. <year>2024</year>. <article-title>The artemisinin-induced dormant stages of Plasmodium falciparum exhibit hallmarks of cellular quiescence/senescence and drug resilience</article-title>. <source>Nat Commun</source><volume>15</volume>:<elocation-id>7485</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41467-024-51846-0</pub-id><pub-id pub-id-type="pmid">39209862</pub-id><pub-id pub-id-type="pmcid">PMC11362153</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Blisnick</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Morales Betoulle</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Barale</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Uzureau</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Berry</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Desroses</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Fujioka</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Mattei</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Braun Breton</surname><given-names>C</given-names></string-name></person-group>. <year>2000</year>. <article-title>Pfsbp1, a Maurer&#8217;s cleft Plasmodium falciparum protein, is associated with the erythrocyte skeleton</article-title>. <source>Mol Biochem Parasitol</source><volume>111</volume>:<fpage>107</fpage>&#8211;<lpage>121</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0166-6851(00)00301-7</pub-id><pub-id pub-id-type="pmid">11087921</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maier</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Rug</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Neill</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Beeson</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Marti</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Reeder</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cowman</surname><given-names>AF</given-names></string-name></person-group>. <year>2007</year>. <article-title>Skeleton-binding protein 1 functions at the parasitophorous vacuole membrane to traffic PfEMP1 to the Plasmodium falciparum-infected erythrocyte surface</article-title>. <source>Blood</source><volume>109</volume>:<fpage>1289</fpage>&#8211;<lpage>1297</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2006-08-043364</pub-id><pub-id pub-id-type="pmid">17023587</pub-id><pub-id pub-id-type="pmcid">PMC1785152</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hanssen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Carlton</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Deed</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Klonis</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sedat</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>DeRisi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Tilley</surname><given-names>L</given-names></string-name></person-group>. <year>2010</year>. <article-title>Whole cell imaging reveals novel modular features of the exomembrane system of the malaria parasite, Plasmodium falciparum</article-title>. <source>Int J Parasitol</source><volume>40</volume>:<fpage>123</fpage>&#8211;<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpara.2009.09.004</pub-id><pub-id pub-id-type="pmid">19766648</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chang</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Meibalan</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Zelin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Daniels</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Eziefula</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Meyer</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Tadesse</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Grignard</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Joice</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wirth</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Volkman</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Buckee</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bousema</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Marti</surname><given-names>M</given-names></string-name></person-group>. <year>2016</year>. <article-title>Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda</article-title>. <source>Sci Rep</source><volume>6</volume>:<elocation-id>26330</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/srep26330</pub-id><pub-id pub-id-type="pmid">27197604</pub-id><pub-id pub-id-type="pmcid">PMC4873826</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tadesse</surname><given-names>FG</given-names></string-name>, <string-name name-style="western"><surname>Lanke</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Nebie</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Schildkraut</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Gon&#231;alves</surname><given-names>BP</given-names></string-name>, <string-name name-style="western"><surname>Tiono</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Sauerwein</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Bousema</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Rijpma</surname><given-names>SR</given-names></string-name></person-group>. <year>2017</year>. <article-title>Molecular markers for sensitive detection of Plasmodium falciparum asexual stage parasites and their application in a malaria clinical trial</article-title>. <source>Am J Trop Med Hyg</source><volume>97</volume>:<fpage>188</fpage>&#8211;<lpage>198</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.16-0893</pub-id><pub-id pub-id-type="pmid">28719294</pub-id><pub-id pub-id-type="pmcid">PMC5508903</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mahamar</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lanke</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Graumans</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Diawara</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sanogo</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Diarra</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Niambele</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Gosling</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Dicko</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bousema</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Roh</surname><given-names>ME</given-names></string-name></person-group>. <year>2021</year>. <article-title>Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians</article-title>. <source>Malar J</source><volume>20</volume>:<elocation-id>34</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s12936-020-03576-z</pub-id><pub-id pub-id-type="pmid">33422068</pub-id><pub-id pub-id-type="pmcid">PMC7797096</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Spielmann</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hawthorne</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Dixon</surname><given-names>MWA</given-names></string-name>, <string-name name-style="western"><surname>Hannemann</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Klotz</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kemp</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Klonis</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Tilley</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Trenholme</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Gardiner</surname><given-names>DL</given-names></string-name></person-group>. <year>2006</year>. <article-title>A cluster of ring stage-specific genes linked to A locus implicated in cytoadherence in Plasmodium falciparum codes for PEXEL-negative and PEXEL-positive proteins exported into the host cell</article-title>. <source>Mol Biol Cell</source><volume>17</volume>:<fpage>3613</fpage>&#8211;<lpage>3624</lpage>. doi:<pub-id pub-id-type="doi">10.1091/mbc.e06-04-0291</pub-id><pub-id pub-id-type="pmid">16760427</pub-id><pub-id pub-id-type="pmcid">PMC1525250</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Joice</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Narasimhan</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Montgomery</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sidhu</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Oh</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Meyer</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pierre-Louis</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Seydel</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Milner</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Williamson</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Wiegand</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ndiaye</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Daily</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wirth</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Taylor</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Huttenhower</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Marti</surname><given-names>M</given-names></string-name></person-group>. <year>2013</year>. <article-title>Inferring developmental stage composition from gene expression in human malaria</article-title>. <source>PLoS Comput Biol</source><volume>9</volume>:<elocation-id>e1003392</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1003392</pub-id><pub-id pub-id-type="pmid">24348235</pub-id><pub-id pub-id-type="pmcid">PMC3861035</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Takano</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kozuka-Hata</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kondoh</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bochimoto</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Oyama</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kato</surname><given-names>K</given-names></string-name></person-group>. <year>2019</year>. <article-title>A high-resolution map of SBP1 interactomes in Plasmodium falciparum-infected erythrocytes</article-title>. <source>iScience</source><volume>19</volume>:<fpage>703</fpage>&#8211;<lpage>714</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.isci.2019.07.035</pub-id><pub-id pub-id-type="pmid">31476617</pub-id><pub-id pub-id-type="pmcid">PMC6728614</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Breglio</surname><given-names>KF</given-names></string-name>, <string-name name-style="western"><surname>Rahman</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>S&#225;</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Hott</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Wellems</surname><given-names>TE</given-names></string-name></person-group>. <year>2018</year>. <article-title>Kelch mutations in Plasmodium falciparum Protein K13 do not modulate dormancy after artemisinin exposure and sorbitol selection in vitro</article-title>. <source>Antimicrob Agents Chemother</source><volume>62</volume>:<elocation-id>e02256-17</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/AAC.02256-17</pub-id><pub-id pub-id-type="pmid">29463530</pub-id><pub-id pub-id-type="pmcid">PMC5923101</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Connelly</surname><given-names>SV</given-names></string-name>, <string-name name-style="western"><surname>Manzella-Lapeira</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Levine</surname><given-names>ZC</given-names></string-name>, <string-name name-style="western"><surname>Brzostowski</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Krymskaya</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Rahman</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Ellis</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Amin</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>S&#225;</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Wellems</surname><given-names>TE</given-names></string-name></person-group>. <year>2021</year>. <article-title>Restructured mitochondrial-nuclear interaction in Plasmodium falciparum dormancy and persister survival after artemisinin exposure</article-title>. <source>MBio</source><volume>12</volume>:<elocation-id>e0075321</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00753-21</pub-id><pub-id pub-id-type="pmid">34044591</pub-id><pub-id pub-id-type="pmcid">PMC8262848</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Klonis</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>McCaw</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Crespo-Ortiz</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Zaloumis</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Tilley</surname><given-names>L</given-names></string-name></person-group>. <year>2013</year>. <article-title>Altered temporal response of malaria parasites determines differential sensitivity to artemisinin</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>110</volume>:<fpage>5157</fpage>&#8211;<lpage>5162</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1217452110</pub-id><pub-id pub-id-type="pmid">23431146</pub-id><pub-id pub-id-type="pmcid">PMC3612604</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Reyser</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Paloque</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ouji</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>M&#233;nard</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Witkowski</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Augereau</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Benoit-Vical</surname><given-names>F</given-names></string-name></person-group>. <year>2020</year>. <article-title>Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent-stage survival assay (QSA)</article-title>. <source>J Antimicrob Chemother</source><volume>75</volume>:<fpage>2826</fpage>&#8211;<lpage>2834</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkaa250</pub-id><pub-id pub-id-type="pmid">32653910</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ezzet</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Mull</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Karbwang</surname><given-names>J</given-names></string-name></person-group>. <year>1998</year>. <article-title>Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients</article-title>. <source>Br J Clin Pharmacol</source><volume>46</volume>:<fpage>553</fpage>&#8211;<lpage>561</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1365-2125.1998.00830.x</pub-id><pub-id pub-id-type="pmid">9862244</pub-id><pub-id pub-id-type="pmcid">PMC1873796</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Micchelli</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Percopo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Traver</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Brzostowski</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Amin</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Prigge</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>S&#225;</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Wellems</surname><given-names>TE</given-names></string-name></person-group>. <year>2024</year>. <article-title>Progressive heterogeneity of enlarged and irregularly shaped apicoplasts in Plasmodium falciparum persister blood stages after drug treatment</article-title>. <source>PNAS Nexus</source><volume>3</volume>:<elocation-id>gae424</elocation-id>. doi:<pub-id pub-id-type="doi">10.1093/pnasnexus/pgae424</pub-id><pub-id pub-id-type="pmcid">PMC11460358</pub-id><pub-id pub-id-type="pmid">39381646</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tucker</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Mutka</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Sparks</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></string-name></person-group>. <year>2012</year>. <article-title>Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum</article-title>. <source>Antimicrob Agents Chemother</source><volume>56</volume>:<fpage>302</fpage>&#8211;<lpage>314</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.05540-11</pub-id><pub-id pub-id-type="pmid">22083467</pub-id><pub-id pub-id-type="pmcid">PMC3256069</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Taliaferro</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Taliaferro</surname><given-names>LG</given-names></string-name></person-group>. <year>1944</year>. <article-title>The effect of immunity on the asexual reproduction of Plasmodium brasilianum</article-title>. <source>J Infect Dis</source><volume>75</volume>:<fpage>1</fpage>&#8211;<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1093/infdis/75.1.1</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jensen</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Boland</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Akood</surname><given-names>M</given-names></string-name></person-group>. <year>1982</year>. <article-title>Induction of crisis forms in cultured Plasmodium falciparum with human immune serum from sudan</article-title>. <source>Science</source><volume>216</volume>:<fpage>1230</fpage>&#8211;<lpage>1233</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.7043736</pub-id><pub-id pub-id-type="pmid">7043736</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Schulman</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Shear</surname><given-names>HL</given-names></string-name></person-group>. <year>1984</year>. <article-title>Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages</article-title>. <source>J Immunol</source><volume>133</volume>:<fpage>1601</fpage>&#8211;<lpage>1608</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.133.3.1601</pub-id><pub-id pub-id-type="pmid">6431003</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dellibovi-Ragheb</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Jhun</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Goodman</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Walters</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Ragheb</surname><given-names>DRT</given-names></string-name>, <string-name name-style="western"><surname>Matthews</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Rajaram</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Mishra</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McFadden</surname><given-names>GI</given-names></string-name>, <string-name name-style="western"><surname>Sinnis</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Prigge</surname><given-names>ST</given-names></string-name></person-group>. <year>2018</year>. <article-title>Host biotin is required for liver stage development in malaria parasites</article-title>. <source>Proc Natl Acad Sci USA</source><volume>115</volume>:<fpage>E2604</fpage>&#8211;<lpage>E2613</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1800717115</pub-id><pub-id pub-id-type="pmid">29483266</pub-id><pub-id pub-id-type="pmcid">PMC5856565</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Goodman</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Mollard</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Louie</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Holloway</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Watson</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>McFadden</surname><given-names>GI</given-names></string-name></person-group>. <year>2014</year>. <article-title>Apicoplast acetyl Co-A carboxylase of the human malaria parasite is not targeted by cyclohexanedione herbicides</article-title>. <source>Int J Parasitol</source><volume>44</volume>:<fpage>285</fpage>&#8211;<lpage>289</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpara.2014.01.007</pub-id><pub-id pub-id-type="pmid">24583112</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>De Niz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ullrich</surname><given-names>A-K</given-names></string-name>, <string-name name-style="western"><surname>Heiber</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Blancke Soares</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pick</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lyck</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Keller</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kaiser</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Prado</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Flemming</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Del Portillo</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Janse</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Heussler</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Spielmann</surname><given-names>T</given-names></string-name></person-group>. <year>2016</year>. <article-title>The machinery underlying malaria parasite virulence is conserved between rodent and human malaria parasites</article-title>. <source>Nat Commun</source><volume>7</volume>:<elocation-id>11659</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/ncomms11659</pub-id><pub-id pub-id-type="pmid">27225796</pub-id><pub-id pub-id-type="pmcid">PMC4894950</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Iriko</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ishino</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Tachibana</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Omoda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Torii</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Tsuboi</surname><given-names>T</given-names></string-name></person-group>. <year>2020</year>. <article-title>Skeleton binding protein 1 (SBP1) of Plasmodium falciparum accumulates in electron-dense material before passing through the parasitophorous vacuole membrane</article-title>. <source>Parasitol Int</source><volume>75</volume>:<fpage>102003</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.parint.2019.102003</pub-id><pub-id pub-id-type="pmid">31669509</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nakamura</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hidema</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sakamoto</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ishida</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Izumi</surname><given-names>M</given-names></string-name></person-group>. <year>2018</year>. <article-title>Selective elimination of membrane-damaged chloroplasts via microautophagy</article-title>. <source>Plant Physiol</source><volume>177</volume>:<fpage>1007</fpage>&#8211;<lpage>1026</lpage>. doi:<pub-id pub-id-type="doi">10.1104/pp.18.00444</pub-id><pub-id pub-id-type="pmid">29748433</pub-id><pub-id pub-id-type="pmcid">PMC6052986</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Woodson</surname><given-names>JD</given-names></string-name></person-group>. <year>2022</year>. <article-title>Control of chloroplast degradation and cell death in response to stress</article-title>. <source>Trends Biochem Sci</source><volume>47</volume>:<fpage>851</fpage>&#8211;<lpage>864</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tibs.2022.03.010</pub-id><pub-id pub-id-type="pmid">35397925</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Dallaporta</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Resche-Rigon</surname><given-names>M</given-names></string-name></person-group>. <year>1998</year>. <article-title>The mitochondrial death/life regulator in apoptosis and necrosis</article-title>. <source>Annu Rev Physiol</source><volume>60</volume>:<fpage>619</fpage>&#8211;<lpage>642</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.physiol.60.1.619</pub-id><pub-id pub-id-type="pmid">9558479</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Totino</surname><given-names>PRR</given-names></string-name>, <string-name name-style="western"><surname>Daniel-Ribeiro</surname><given-names>CT</given-names></string-name>, <string-name name-style="western"><surname>Corte-Real</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>de F&#225;tima Ferreira-da-Cruz</surname><given-names>M</given-names></string-name></person-group>. <year>2008</year>. <article-title>Plasmodium falciparum: erythrocytic stages die by autophagic-like cell death under drug pressure</article-title>. <source>Exp Parasitol</source><volume>118</volume>:<fpage>478</fpage>&#8211;<lpage>486</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.exppara.2007.10.017</pub-id><pub-id pub-id-type="pmid">18226811</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>L&#243;pez</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Vommaro</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Zalis</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>de Souza</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Blair</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Segura</surname><given-names>C</given-names></string-name></person-group>. <year>2010</year>. <article-title>Induction of cell death on Plasmodium falciparum asexual blood stages by Solanum nudum steroids</article-title>. <source>Parasitol Int</source><volume>59</volume>:<fpage>217</fpage>&#8211;<lpage>225</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.parint.2010.02.002</pub-id><pub-id pub-id-type="pmid">20153445</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gaviria</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Paguio</surname><given-names>MF</given-names></string-name>, <string-name name-style="western"><surname>Turnbull</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Siriwardana</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ghosh</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ferdig</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Sinai</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Roepe</surname><given-names>PD</given-names></string-name></person-group>. <year>2013</year>. <article-title>A process similar to autophagy is associated with cytocidal chloroquine resistance in Plasmodium falciparum</article-title>. <source>PLoS ONE</source><volume>8</volume>:<elocation-id>e79059</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0079059</pub-id><pub-id pub-id-type="pmid">24278114</pub-id><pub-id pub-id-type="pmcid">PMC3835802</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tomlins</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Ben-Rached</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Proto</surname><given-names>WR</given-names></string-name>, <string-name name-style="western"><surname>Coppens</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Ruch</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Gilberger</surname><given-names>TW</given-names></string-name>, <string-name name-style="western"><surname>Coombs</surname><given-names>GH</given-names></string-name>, <string-name name-style="western"><surname>Mottram</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>M&#252;ller</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Langsley</surname><given-names>G</given-names></string-name></person-group>. <year>2013</year>. <article-title>Plasmodium falciparum ATG8 implicated in both autophagy and apicoplast formation</article-title>. <source>Autophagy</source><volume>9</volume>:<fpage>1540</fpage>&#8211;<lpage>1552</lpage>. doi:<pub-id pub-id-type="doi">10.4161/auto.25832</pub-id><pub-id pub-id-type="pmid">24025672</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Engelbrecht</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Durand</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Coetzer</surname><given-names>TL</given-names></string-name></person-group>. <year>2012</year>. <article-title>On programmed cell death in Plasmodium falciparum: status quo</article-title>. <source>J Trop Med</source><volume>2012</volume>:<elocation-id>646534</elocation-id>. doi:<pub-id pub-id-type="doi">10.1155/2012/646534</pub-id><pub-id pub-id-type="pmid">22287973</pub-id><pub-id pub-id-type="pmcid">PMC3263642</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Duszenko</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ginger</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Brennand</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gualdr&#243;n-L&#243;pez</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Colombo</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Coombs</surname><given-names>GH</given-names></string-name>, <string-name name-style="western"><surname>Coppens</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Jayabalasingham</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Langsley</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>de Castro</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Menna-Barreto</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Mottram</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Navarro</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rigden</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Romano</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Stoka</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Turk</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Michels</surname><given-names>PAM</given-names></string-name></person-group>. <year>2011</year>. <article-title>Autophagy in protists</article-title>. <source>Autophagy</source><volume>7</volume>:<fpage>127</fpage>&#8211;<lpage>158</lpage>. doi:<pub-id pub-id-type="doi">10.4161/auto.7.2.13310</pub-id><pub-id pub-id-type="pmid">20962583</pub-id><pub-id pub-id-type="pmcid">PMC3039767</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Coppens</surname><given-names>I</given-names></string-name></person-group>. <year>2011</year>. <article-title>Metamorphoses of malaria: the role of autophagy in parasite differentiation</article-title>. <source>Essays Biochem</source><volume>51</volume>:<fpage>127</fpage>&#8211;<lpage>136</lpage>. doi:<pub-id pub-id-type="doi">10.1042/bse0510127</pub-id><pub-id pub-id-type="pmid">22023446</pub-id><pub-id pub-id-type="pmcid">PMC4109265</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cervantes</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bunnik</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Saraf</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Conner</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Escalante</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sardiu</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Ponts</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Prudhomme</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Florens</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Le Roch</surname><given-names>KG</given-names></string-name></person-group>. <year>2014</year>. <article-title>The multifunctional autophagy pathway in the human malaria parasite, Plasmodium falciparum</article-title>. <source>Autophagy</source><volume>10</volume>:<fpage>80</fpage>&#8211;<lpage>92</lpage>. doi:<pub-id pub-id-type="doi">10.4161/auto.26743</pub-id><pub-id pub-id-type="pmid">24275162</pub-id><pub-id pub-id-type="pmcid">PMC4028325</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mizushima</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sahani</surname><given-names>MH</given-names></string-name></person-group>. <year>2014</year>. <article-title>ATG8 localization in apicomplexan parasites: apicoplast and more?</article-title><source>Autophagy</source><volume>10</volume>:<fpage>1487</fpage>&#8211;<lpage>1494</lpage>. doi:<pub-id pub-id-type="doi">10.4161/auto.32183</pub-id><pub-id pub-id-type="pmid">25102412</pub-id><pub-id pub-id-type="pmcid">PMC4206529</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Navale</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Allanki</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Sijwali</surname><given-names>PS</given-names></string-name></person-group>. <year>2014</year>. <article-title>Characterization of the autophagy marker protein Atg8 reveals atypical features of autophagy in Plasmodium falciparum</article-title>. <source>PLoS ONE</source><volume>9</volume>:<elocation-id>e113220</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0113220</pub-id><pub-id pub-id-type="pmid">25426852</pub-id><pub-id pub-id-type="pmcid">PMC4245143</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Subramani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Malhotra</surname><given-names>V</given-names></string-name></person-group>. <year>2013</year>. <article-title>Non-autophagic roles of autophagy-related proteins</article-title>. <source>EMBO Rep</source><volume>14</volume>:<fpage>143</fpage>&#8211;<lpage>151</lpage>. doi:<pub-id pub-id-type="doi">10.1038/embor.2012.220</pub-id><pub-id pub-id-type="pmid">23337627</pub-id><pub-id pub-id-type="pmcid">PMC3566844</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Inoue</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ishihara</surname><given-names>K</given-names></string-name></person-group>. <year>2015</year>. <article-title>Preparation of photoreactive phospholipid polymer nanoparticles to immobilize and release protein by photoirradiation</article-title>. <source>Colloids Surf B Biointerfaces</source><volume>135</volume>:<fpage>365</fpage>&#8211;<lpage>370</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.colsurfb.2015.07.073</pub-id><pub-id pub-id-type="pmid">26263222</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maerki</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Brun</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Charman</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Dorn</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Matile</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wittlin</surname><given-names>S</given-names></string-name></person-group>. <year>2006</year>. <article-title>In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum</article-title>. <source>J Antimicrob Chemother</source><volume>58</volume>:<fpage>52</fpage>&#8211;<lpage>58</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkl209</pub-id><pub-id pub-id-type="pmid">16735432</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sanz</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Crespo</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>De-C&#243;zar</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>XC</given-names></string-name>, <string-name name-style="western"><surname>Llergo</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Burrows</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Garc&#237;a-Bustos</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Gamo</surname><given-names>F-J</given-names></string-name></person-group>. <year>2012</year>. <article-title>P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</article-title>. <source>PLoS ONE</source><volume>7</volume>:<elocation-id>e30949</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0030949</pub-id><pub-id pub-id-type="pmid">22383983</pub-id><pub-id pub-id-type="pmcid">PMC3285618</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Amaratunga</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sreng</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Suon</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Phelps</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Stepniewska</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Lindegardh</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Su</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>NJ</given-names></string-name>, <string-name name-style="western"><surname>Dondorp</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>TJC</given-names></string-name>, <string-name name-style="western"><surname>Fay</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Mu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Duong</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Fairhurst</surname><given-names>RM</given-names></string-name></person-group>. <year>2012</year>. <article-title>Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study</article-title>. <source>Lancet Infect Dis</source><volume>12</volume>:<fpage>851</fpage>&#8211;<lpage>858</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(12)70181-0</pub-id><pub-id pub-id-type="pmid">22940027</pub-id><pub-id pub-id-type="pmcid">PMC3786328</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sullivan</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Sullivan</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Grady</surname><given-names>KK</given-names></string-name>, <string-name name-style="western"><surname>Bounngaseng</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Huber</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Nace</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Galland</surname><given-names>GG</given-names></string-name>, <string-name name-style="western"><surname>Barnwell</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Collins</surname><given-names>WE</given-names></string-name></person-group>. <year>2003</year>. <article-title>Adaptation of a strain of Plasmodium falciparum from Ghana to Aotus lemurinus griseimembra, A. nancymai, and A. vociferans monkeys</article-title>. <source>Am J Trop Med Hyg</source><volume>69</volume>:<fpage>593</fpage>&#8211;<lpage>600</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.2003.69.593</pub-id><pub-id pub-id-type="pmid">14740874</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hayton</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Gaur</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Takahashi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Henschen</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lambert</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Furuya</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bouttenot</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Doll</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nawaz</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Mu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Wellems</surname><given-names>TE</given-names></string-name></person-group>. <year>2008</year>. <article-title>Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion</article-title>. <source>Cell Host Microbe</source><volume>4</volume>:<fpage>40</fpage>&#8211;<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2008.06.001</pub-id><pub-id pub-id-type="pmid">18621009</pub-id><pub-id pub-id-type="pmcid">PMC2677973</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>